Ultimately, the interview underscores a critical transition period for the industry. While tariffs present a unique hurdle ...
Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...
Repertoire Immune Medicines partners with Eli Lilly to develop tolerizing therapies for autoimmune diseases, receiving $85 ...
Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026 ...
With a potential US government shutdown looming, Megha Sinha, Kamet Consulting, says to treat FDA disruptions as predictable ...
The CDA-200 Dual Shaft Mixer efficiently processes high-viscosity formulations with dual agitators, ensuring uniform mixing and dispersion. Contamination risks are minimized with no submerged bearings ...
Government shutdowns lead to decreased predictability, causing delays in new submissions and manufacturing changes. Key risk ...
Rare disease clinical trials are smaller and often use surrogate endpoints, reducing costs but posing unique operational ...
HanchorBio and WuXi Biologics collaborate to develop fusion proteins using the Fc-Based Designer Biologics platform, ...
February 11 is the International Day of Women and Girls in Science (1). This day focuses on the gender gap in science, ...
Mirum Pharmaceuticals acquires Bluejay Therapeutics, focusing on brelovitug for chronic hepatitis delta virus (HDV), a severe ...
Arexvy, GSK's RSV vaccine, is now approved for all adults 18+ in the EU, addressing a significant public health concern. RSV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results